ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 4 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 4 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

14 3 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

06 3 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 2 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 2 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones

09 1 2023 07:00:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

21 12 2022 16:48:37 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting

13 12 2022 07:00:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference

08 11 2022 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update

07 11 2022 15:05:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting

03 11 2022 08:00:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

07 10 2022 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 9 2022 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

11 8 2022 15:05:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference

02 6 2022 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

17 5 2022 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update

09 5 2022 15:05:03 提供 Nasdaq GlobeNewswire